2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$2.56-$0.07 (-2.85%)
Price as of Oct 02, 2026 5:07 PM EDT- $573.1MMarket Cap
- -19.82%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$2.56-$0.07 (-2.85%)
CTMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.63 | ||
Change | -$0.09 (-3.31%) | ||
Open | $2.71 | ||
High | $2.77 | ||
Low | $2.62 | ||
Previous Close | $2.72 | ||
Volume | 2,697,829 | ||
30-Day Average Volume | 4,417,248 | ||
1-Week Change | -4.36% | ||
1-Month Change | -28.34% | ||
1-Year Change | -19.82% | ||
3-Year Change | 103.88% | ||
5-Year Change | -48.53% | ||
Fundamentals | |||
Shares Outstanding | 217.9M | ||
Total Assets | $381.2M | ||
Market Cap | $573.1M | ||
Enterprise Value | $555.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.7M | ||
Free Cash Flow | -$18.1M | ||
EBIT | -$20.6M | ||
EBITDA | -$20.6M | ||
Net Working Capital | $333.3M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 392 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue